Cortes JE, Kantarjian HM, Goldberg SL, Powell BL, Giles FJ, Wetzler M, Akard L, Burke JM, Kerr R, Saleh M, Salvado A, McDougall K, Albitar M, Radich J, Rationale and Insight for Gleevec High-Dose Therapy (RIGHT) Trial Study Group and Leonard Kalman. "High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: high rates of rapid cytogenetic and molecular responses" Journal of Clinical Oncology Vol. 27 Iss. 28 (2009) p. 4754 - 4759
Available at: http://works.bepress.com/leonard-kalman/28/